Join
Live feed
·
NEWSReleasevia Quantisnow
Myomo Inc. logo

Myomo Says Given Our Backlog, We're In A Position To Generate More Than $5M In Product Revenue In Q2 Vs $5.12M Est; Says Have The Opportunity To Generate Between $28M-$30M In Revenue In FY24 Vs 26.67M Est.

ByQuantisnow·Wall Street's wire, on your screen.
MYO· Myomo Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYO (Myomo Inc.) and more on Quantisnow.